| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.09 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.48 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |